A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy

Gareth Lewis, Alexander P. Maxwell

Research output: Contribution to journalArticlepeer-review

Abstract

Erythropoiesis stimulating agents (ESAs) are used to mange anaemia secondary to chronic kidney disease (CKD). ESAs have also been used to augment the rate of iron loss by phlebotomy in some iron storage disorders. We report the use of erythropoietin to allow enhanced iron removal in a man with both hereditary haemochromatosis and CKD. The patient subsequently presented with more severe anaemia that prompted a search for an underlying occult malignancy. The case history illustrates the importance of considering alternative causes for anaemia in patients with CKD.

Original languageEnglish
Pages (from-to)145-147
Number of pages3
JournalNDT Plus
Volume3
Issue number2
DOIs
Publication statusPublished - 01 Apr 2010
Externally publishedYes

Keywords

  • colorectal carcinoma
  • erythropoietin
  • haemochromatosis

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Fingerprint Dive into the research topics of 'A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy'. Together they form a unique fingerprint.

Cite this